----
Q2 FY2026 EarningsQ2 FY26 performance beat consensus across all key financial metrics, with revenue of $10.8B vs. $10.66B expected and Diluted EPS of $2.21 vs. $2.01 mean estimate. Growth was primarily driven by the Americas Materials Solutions segment (+10% YoY) and significant gains from divestitures. Management reaffirmed FY26 guidance for Net Income ($3.9B-$4.1B) and Adjusted EBITDA ($8.1B-$8.5B) while narrowing Capex guidance to $2.7B-$2.9B due to project timing.
Financial report interval: 2026.03.30 - 2026.06.30
Overview: CRH(CRH) the Revenue is 10.78 B (+5.59%), Beat estimate;the EBIT is 2.079 B (+7.44%), Beat estimate;the EPS is 2.21 (+13.92%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
10.78B5.59%
10.66B4.41%
+0.12B1.18%
EBITExceed expectations
2.08B7.44%
1.98B2.13%
+0.10B5.31%
EPSExceed expectations
2.2113.92%
2.00663.43%
+0.203410.49%
Upcoming earnings report - Q3 FY2026
Available dateOct 29, 2026
Estimate Revenue$11.56 B
Estimate EBIT$2.11 B
Estimate EPS$2.0697
Revenue
ActualEstimateUnit: USD
Quarterly
EBIT
ActualEstimateUnit: USD
Quarterly
Net income
ActualEstimateUnit: USD
Quarterly
EPS
ActualEstimateUnit: USD
Quarterly
